Int J Rheum Dis. 2025 Oct;28(10):e70443. doi: 10.1111/1756-185x.70443. NO ABSTRACT PMID:41116187 | DOI:10.1111/1756-185x.70443 Read More
2025
Genome Biol. 2025 Oct 20;26(1):358. doi: 10.1186/s13059-025-03771-8. ABSTRACT The field of single-cell biology is growing rapidly, generating… Read More
Sci Rep. 2025 Oct 20;15(1):36474. doi: 10.1038/s41598-025-24189-z. ABSTRACT Cardiovascular diseases (CVDs) are the leading cause of death… Read More
Cell Mol Immunol. 2025 Oct 20. doi: 10.1038/s41423-025-01355-x. Online ahead of print. ABSTRACT Inflammasomes, particularly NLRC4, play… Read More
Clin Rheumatol. 2025 Oct 20. doi: 10.1007/s10067-025-07718-z. Online ahead of print. ABSTRACT OBJECTIVES: Cardiovascular involvement is an… Read More
Nat Genet. 2025 Oct 20. doi: 10.1038/s41588-025-02344-6. Online ahead of print. ABSTRACT Identifying response expression quantitative trait… Read More
Blood Cancer J. 2025 Oct 20;15(1):167. doi: 10.1038/s41408-025-01380-z. NO ABSTRACT PMID:41115897 | DOI:10.1038/s41408-025-01380-z Read More
Autoimmun Rev. 2025 Oct 18:103943. doi: 10.1016/j.autrev.2025.103943. Online ahead of print. ABSTRACT Immune checkpoint inhibitors (ICIs) have… Read More
SGLT-2 inhibitors for the prevention of autoimmune rheumatic diseases jjcush@gmail.com Tue, 10/21/2025 – 00:31 Read More
Rheumatology. News · CPD. Specialities. Cardiology · Dermatology · Endocrinology … Rheumatology. Have a comment or a… Read More
About. About the limbic · Contact. Rheumatology. News · CPD. Specialities … Rheumatology. Have a comment or… Read More
Telitacicept Effective in Systemic Lupus Erythematosus The NEJM has published a report from van Vollenhoven et al… Read More
… Rheumatology. Researchers conducted a multicenter, open-label, 2-arm … Rheumatology clinical response (disease activity score 28 with… Read More
Biomol Biomed. 2025 Oct 20. doi: 10.17305/bb.2025.13043. Online ahead of print. ABSTRACT Assessment of insulin resistance is… Read More
SAIL-RA: Finding ILD in Early RA Cohort study of early rheumatoid arthritis (RA) patients finds that interstitial… Read More
FDA Approves Obinutuzumab for Active Lupus Nephritis jjcush@gmail.com Mon, 10/20/2025 – 18:17 Read More
FDA has approved Genentech’s CD20-targeting antibody obinutuzumab (Gazyva) for the treatment of adult patients with lu https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg… Read More
(MedPage Today) — Chimeric antigen receptor (CAR) T-cell therapy for blood cancers appeared less toxic, and patients’… Read More
Poster to be presented at American College of Rheumatology Convergence 2025 –BRISBANE, Calif., Oct. 20, 2025 (GLOBE… Read More
Retrospective study of 423 seropositiv RA pts (SPRA) finds 21% with baseline ILD; over 10 yrs 31%… Read More
Department of Rheumatology, Shaoxing Shangyu District Hospital of Traditional Chinese Medicine, Shaoxing, Zhejiang Province, 312300, People’s Republic … Read More
For more information: Shivani Garg, MD, PhD, can be reached at sgarg@medicine.wisc.edu. Published by: healio rheumatology logo.… Read More
Interleukin-18 (IL-18) regulates appetite, body weight & glucose homeostasis. IL-18 deficiency may lead to obesity, https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…… Read More
The FDA has approved obinutuzumab for the treatment of adults with active lupus nephritis who are receiving… Read More
… rheumatology. These events bring together researchers, clinicians and stakeholders to drive progress in arthritis care and… Read More